Apoptosis (13)
Breast cancer (7)
Photodynamic therapy (7)
apoptosis (6)
Triple negative breast cancer (4)
Drug delivery system (3)
Inflammation (3)
ZIF-8 (3)
5-Aminolevulinic acid (2)
Abemaciclib (2)
ATR (2)
Cabazitaxel (2)
Canine mammary gland tumor (2)
DNA damage response (2)
Drug delivery (2)
Gallic acid (2)
Gemcitabine (2)
Oxidant damage (2)
Talazoparib (2)
Tight junctions (2)
triple-negative breast cancer (2)
Triple-negative breast cancer (2)
Ulcerative colitis (2)
Zinc (2)
Zinc picolinate (2)
3-dioxygenase (IDO) (1)
5-ALA (1)
5-aminolaevulinic acid (1)
5-Aminolevulic acid (5-ALA) (1)
5-aminolevulinic acid (1)
5-Fluorouracil (1)
5-FU (1)
5-Sulfosalicylic acid (1)
6 inhibitors (1)
abemaciclib (1)
AKT (1)
antibacterial efficacy (1)
antibacterial properties (1)
Antibiofilm activity (1)
Anticancer effect (1)
anti-freezing (1)
ATR inhibitors (1)
atypical cell death (1)
Au (1)
Automated experiment (1)
B activity (1)
bee venom (1)
Bioactivity (1)
Boswellic acid (1)
Box-Behnken Design (1)
breast cancer (1)
c.1103A > G (1)
cabazitaxel (1)
caffeic acid (1)
caffeic acid (CA) (1)
cancer (1)
Cancer Therapy (1)
canine mammary gland tumour (1)
Canine mammary tumors (1)
Carcinoma (1)
Carcinosarcoma (1)
Castration resistant metastatic prostate cancer (1)
CDK4 (1)
CDK4/6 inhibitors (1)
cell cycle (1)
Cell cycle (1)
cells (1)
characterization (1)
CHEK2 gene (1)
Chitosan hydrogels (1)
Cisplatin (1)
Coelomic fluid (1)
Colorectal cancer (1)
Combination therapy (1)
Combined therapy (1)
complete response (1)
Confocal Microscopy (1)
contrast media (1)
contrast-induced nephropathy (1)
Curcumin (1)
DFT (1)
DHEA-induced PCOS (1)
Docking (1)
dopamine transporter (1)
Dosage control (1)
Dosimetry (1)
drug delivery systems (1)
Drug Delivery Systems (1)
drug release (1)
Drug resistance (1)
Early-onset breast cancer (1)
Eisenia foetida (1)
Embedded systems (1)
endodontic disinfection (1)
Epacadostat (1)
epithelial-mesenchymal transition (1)
Exosomes (1)
Fatty acid profile (1)
Feline mammary gland tumor (1)
Fluorescent (1)
Gastric ulcer (1)
gene expression (1)
Genistein (1)
Glioblastoma (1)
Glucose oxidase (1)
granulosa cell proliferation (1)
hepatitis B (1)
hepatitis B vaccine response (1)
Hepatocellular carcinoma (1)
histone deacetylase inhibitor (1)
honey bee (1)
hydrogel (1)
hypochlorous acid (1)
indoleamine 2 (1)
indoleamine 2,3-dioxygenase (1)
indoleamine 2,3-dioxygenase inhibitors (1)
indoximod (1)
inflammation (1)
inhibitors (1)
irrigation solutions (1)
kidney injury (1)
Lauric acid (1)
Lenalidomide-like novel drug derivative (1)
Light-emitting diodes (LEDs) (1)
Lipid hydrolysis (1)
Liver metastasis (1)
MCF-7 cells (1)
MCF-7 cytotoxicity (1)
Meclofenamic acid (MA) (1)
metabolic dysfunction-associated steatotic liver disease (1)
Metastatic castration-resistant prostate cancer (1)
methamphetamine (1)
MIL-100 (1)
MIL-100 (Fe) (1)
microRNA (1)
MiR-135b (1)
MiR-99b (1)
miRNA (1)
MiRNA (1)
MMPs (1)
mTOR signaling (1)
Multidrug resistance (1)
Multiple real samples (1)
Nano-antibiotic (1)
NF-κ (1)
Non-thermal processing (1)
ovarian folliculogenesis (1)
Oxidative damage (1)
Oxidative stability (1)
PARP inhibitor resistance (1)
PARP inhibitors (1)
PCOS (1)
Peritonitis carcinomatosis (1)
phoenixin-14 (1)
Phosphatidylinositol 3-kinase (PI3K) (1)
PI3K (1)
Poly (ADP -ribose) polymerase (PARP) (1)
pro-inflammatory cytokines (1)
prostate cancer (1)
Prostate Cancer (1)
psychic experiences (1)
Quercetin (1)
radiotherapy (1)
reactive oxygen species (1)
Receptor tyrosine kinases (1)
Resistance (1)
rutaecarpine (1)
self-healing (1)
silver nanoparticles (1)
Silver nanoparticles (1)
SLNs (1)
Small cell lung carcinoma (SCLC) (1)
snail (1)
sodium butyrate (1)
Solid lipid nanoparticles (1)
solid lipid nanoparticles (SLNs). (1)
subtype (1)
Surgical treatment (1)
Synergism (1)
tannic acid (1)
Taxanes (1)
TEM (1)
Thermal processing (1)
Thiazolidine-4-one (1)
Thyroid cancer (1)
TIMPs (1)
TLR3 (1)
toll-like receptor 4 (1)
Topotecan (TPT) (1)
triple negative breast cancer (1)
triple negative breast cancer (TNBC) (1)
Triple negative breast cancer cells (1)
tumor necrosis factor-alpha (1)
Vanillic acid (1)
Variant of uncertain significance (1)
vesicular monoamine transporter (1)
